speb/financial-data huggingface dataset:
Financial ratios for AG — quarterly report dated 2025-09-30
Total revenue: 206275539.56834534
Gross profit: 71281294.96402878
Operating income: 55302877.69784173
Net income: 30907913.66906475
Capital expenditures: 12332374.100719426
Operating cash flow: 80949640.2877698
Depreciation & amortization: 39708633.093525186
Net tangible assets: 1870172661.8705037
Owner earnings: 58284172.66187051
Return on net tangible assets (%): 3.1165129215168843
Capex to operating income (%): 22.299696894797776
Buffett classification: The Great
Stock price: 12.28
P/E ratio: 79.18875739717737
Shares outstanding: 493769568
Book value: 2163625899.2805758
P/B ratio: 2.8024670517468673
Market cap (USD): 6063490295.04
Debt to equity: 0.07886208868672359
Current ratio: 3.3793902171528845
Quick ratio: 2.9572274621627552
Effective tax rate (%): 35.21819113966042
Interest coverage ratio: 17.761321626617377
COGS to revenue (%): 65.44365118947556
SG&A to revenue (%): 5.1241093320033615
Free cash flow (dilution-adjusted): 37861870.503597125
Buyback yield (%): 0
Retained earnings: -462269784.1726619
Inventory turnover: 1.949891927841051
Receivables turnover: 3.447308621788321
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.918154483412559
FCF margin (%): 18.35499768068833
Revenue growth (%): 6.750938407497988
Rule of 40 score: 25.10593608818632
Financial ratios for AG — annual report dated 2025-12-31
Total revenue: 923472262.7737225
Gross profit: 328500000
Operating income: 255424087.59124085
Net income: 153996350.3649635
Capital expenditures: 48975182.48175182
Operating cash flow: 383948905.109489
Depreciation & amortization: 193283211.6788321
Net tangible assets: 2015332116.788321
Owner earnings: 298304379.5620438
Return on net tangible assets (%): 14.801747914255861
Capex to operating income (%): 19.17406574438961
Buffett classification: The Great
Stock price: 16.64
P/E ratio: 53.35402814448347
Shares outstanding: 493769568
Book value: 2316033576.642336
P/B ratio: 3.547584842630649
Market cap (USD): 8216325611.52
Debt to equity: 0.09730328027467043
Current ratio: 2.5976904597518398
Quick ratio: 2.413099301083114
Effective tax rate (%): 46.59212305012835
Interest coverage ratio: 23.643986486486487
COGS to revenue (%): 64.4277350558073
SG&A to revenue (%): 5.338942123388639
Free cash flow (dilution-adjusted): 217302919.70802918
Buyback yield (%): 0.07724517781486785
Retained earnings: -410200729.92700726
Inventory turnover: 9.617500265477327
Receivables turnover: 10.356302644826993
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.26131976761755
FCF margin (%): 23.531071637749307
Revenue growth (%): 134.29607948576697
Rule of 40 score: 157.82715112351627
Financial ratios for AG — quarterly report dated 2025-12-31
Total revenue: 341398540.14598536
Gross profit: 173582481.7518248
Operating income: 153474452.5547445
Net income: 76783941.60583942
Capital expenditures: 12018248.17518248
Operating cash flow: 195541605.83941606
Depreciation & amortization: 53117518.24817518
Net tangible assets: 2015332116.788321
Owner earnings: 117883211.67883213
Return on net tangible assets (%): 5.849319360160522
Capex to operating income (%): 7.830780937886426
Buffett classification: The Great
Stock price: 16.64
P/E ratio: 53.57749982774866
Shares outstanding: 493769568
Book value: 2316033576.642336
P/B ratio: 3.547584842630649
Market cap (USD): 8216325611.52
Debt to equity: 0.09730328027467043
Current ratio: 2.5976904597518398
Quick ratio: 2.413099301083114
Effective tax rate (%): 59.794373948937476
Interest coverage ratio: 169.42788074133762
COGS to revenue (%): 49.15547041366983
SG&A to revenue (%): 4.0607975780174295
Free cash flow (dilution-adjusted): 159031386.86131385
Buyback yield (%): 0.03931108819215529
Retained earnings: -410200729.92700726
Inventory turnover: 2.712682736894269
Receivables turnover: 3.8286224143153
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.96390743986462
FCF margin (%): 46.58232773734488
Revenue growth (%): 65.50607059877291
Rule of 40 score: 112.08839833611779
Financial ratios for ALKEM.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 45.83608070684426
Shares outstanding: 119565000
Market cap (USD): 5480390989.713834
Buyback yield (%): 0
Retained earnings: 869562178.5572993
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALKEM.NS — annual report dated 2023-03-31
Total revenue: 1393465286.2362974
Gross profit: 786605359.3179051
Operating income: 162505481.12058467
Net income: 122632155.90742998
Capital expenditures: 27979293.54445798
Operating cash flow: 204933008.5261876
Depreciation & amortization: 37809987.81973204
Net tangible assets: 1041746650.4263095
Owner earnings: 132462850.18270403
Return on net tangible assets (%): 12.715457268664778
Capex to operating income (%): 17.217446052601993
Buffett classification: The Great
Stock price: 40.247259439707676
P/E ratio: 39.24063423088766
Shares outstanding: 119565000
Book value: 1149208282.5822167
P/B ratio: 4.187372861685215
Market cap (USD): 4812163574.9086485
Debt to equity: 0.14803179650238477
Current ratio: 2.3548224377217
Quick ratio: 1.651443831514776
Effective tax rate (%): 22.836208680457094
Interest coverage ratio: 14.231146666666666
COGS to revenue (%): 43.55041585266185
SG&A to revenue (%): 14.109883001831236
Free cash flow (dilution-adjusted): 176563946.40682095
Buyback yield (%): 0
Retained earnings: 858948842.8745433
Inventory turnover: 1.9107431170494684
Receivables turnover: 5.365564820981343
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.275983879795017
FCF margin (%): 12.670853601506945
Rule of 40 score: 12.670853601506945
Financial ratios for ALKEM.NS — annual report dated 2024-03-31
Total revenue: 1491694447.7755127
Gross profit: 888292361.1943878
Operating income: 238021345.48507014
Net income: 217227485.3099892
Capital expenditures: 22401966.662669383
Operating cash flow: 233609545.50905386
Depreciation & amortization: 35891593.716272935
Net tangible assets: 1179726585.9215734
Owner earnings: 230717112.36359277
Return on net tangible assets (%): 19.556829109124656
Capex to operating income (%): 9.411746924216317
Buffett classification: The Great
Stock price: 58.20285508637236
P/E ratio: 32.035653124057504
Shares outstanding: 119565000
Book value: 1284854299.0766277
P/B ratio: 5.416197286652095
Market cap (USD): 6959024368.402111
Debt to equity: 0.13238352124244007
Current ratio: 2.60644628306067
Quick ratio: 1.940243581880312
Effective tax rate (%): 10.462501173923574
Interest coverage ratio: 20.738271862919234
COGS to revenue (%): 40.45078316681726
SG&A to revenue (%): 12.740087014962329
Free cash flow (dilution-adjusted): 200244633.6491186
Buyback yield (%): 0
Retained earnings: 996486389.2553064
Inventory turnover: 1.8908040793933518
Receivables turnover: 5.5216551773118905
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.13989646254215
FCF margin (%): 13.423971239400478
Revenue growth (%): 7.049272235875281
Rule of 40 score: 20.47324347527576
Financial ratios for ALKEM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1308586956.5217392
Buffett classification: The Gruesome
Stock price: 71.04085045389394
Shares outstanding: 119565000
Book value: 1422608695.652174
P/B ratio: 5.970720768458315
Market cap (USD): 8493999284.519829
Debt to equity: 0.1240881673338886
Current ratio: 2.659249329758713
Quick ratio: 1.9621553044810418
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALKEM.NS — annual report dated 2025-03-31
Total revenue: 1515609071.7792845
Gross profit: 958646247.3696516
Operating income: 251927753.09796584
Net income: 258987608.1365443
Capital expenditures: 74208557.40004675
Operating cash flow: 223619359.3640402
Depreciation & amortization: 41753565.58335281
Net tangible assets: 1338226560.6733692
Owner earnings: 226532616.31985033
Return on net tangible assets (%): 16.927822461232843
Capex to operating income (%): 29.45628517997763
Buffett classification: The Good
Stock price: 56.42093593184736
P/E ratio: 26.047459387071125
Shares outstanding: 119565000
Book value: 1453545709.6095395
P/B ratio: 4.641043731953551
Market cap (USD): 6745969204.69133
Debt to equity: 0.11106169316603437
Current ratio: 2.760624265443962
Quick ratio: 2.0235688452400766
Effective tax rate (%): 12.308124557286618
Interest coverage ratio: 17.707395234182414
COGS to revenue (%): 36.74844884345892
SG&A to revenue (%): 12.419356829253996
Free cash flow (dilution-adjusted): 142694645.77975217
Buyback yield (%): 0
Retained earnings: 1165888473.2288988
Inventory turnover: 1.6302503755462103
Receivables turnover: 5.25677445514445
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.699921026480897
FCF margin (%): 9.41500340930478
Revenue growth (%): 1.6031851589602975
Rule of 40 score: 11.018188568265078
Financial ratios for ALKEM.NS — quarterly report dated 2025-03-31
Total revenue: 367518120.1776946
Gross profit: 217964694.87958848
Operating income: 32592938.975917697
Net income: 37688800.561140984
Capital expenditures: 0
Depreciation & amortization: 13150572.831423894
Net tangible assets: 1338226560.6733692
Owner earnings: 50839373.39256488
Return on net tangible assets (%): 3.7990109363083864
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 56.42093593184736
P/E ratio: 44.74783691873944
Shares outstanding: 119565000
Book value: 1453545709.6095395
P/B ratio: 4.641043731953551
Market cap (USD): 6745969204.69133
Debt to equity: 0.11106169316603437
Current ratio: 2.760624265443962
Quick ratio: 2.0235688452400766
Effective tax rate (%): 18.50179139122975
Interest coverage ratio: 9.809992962702323
COGS to revenue (%): 40.69280318091451
Buyback yield (%): 0
Retained earnings: 1165888473.2288988
Inventory turnover: 0.4377482967824501
Receivables turnover: 1.2747085656360873
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0311639414488583
Rule of 40 score: 0
Financial ratios for ALKEM.NS — quarterly report dated 2025-06-30
Total revenue: 394469927.4514393
Gross profit: 257428036.508308
Operating income: 76219283.87549731
Net income: 78154692.25368594
Capital expenditures: 0
Depreciation & amortization: 10259770.652937047
Owner earnings: 88414462.90662298
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 57.23683594664171
P/E ratio: 21.890951434324986
Shares outstanding: 119565000
Market cap (USD): 6843522289.9602165
Effective tax rate (%): 13.3188933995668
Interest coverage ratio: 21.872733378106112
COGS to revenue (%): 34.74077018456664
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 7.333463520305755
Rule of 40 score: 7.333463520305755
Financial ratios for ALKEM.NS — quarterly report dated 2025-09-30
Total revenue: 451069898.53438556
Gross profit: 293118376.5501691
Operating income: 93253664.03607666
Net income: 87836527.62119503
Capital expenditures: 0
Depreciation & amortization: 10553551.296505073
Net tangible assets: 1410631341.6009018
Owner earnings: 98390078.91770011
Return on net tangible assets (%): 6.97489670164558
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 60.67215332581736
P/E ratio: 35.615992166889995
Shares outstanding: 119565000
Book value: 1557038331.4543402
P/B ratio: 4.659015687574986
Market cap (USD): 7254266012.401353
Debt to equity: 0.17056056326402352
Current ratio: 2.4858600125871
Quick ratio: 1.8693463113031747
Effective tax rate (%): 12.974559905339184
Interest coverage ratio: 23.619645916619078
COGS to revenue (%): 35.0170832718902
Buyback yield (%): 0
Inventory turnover: 0.46586707278144285
Receivables turnover: 1.294182149880965
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.367878391427593
Revenue growth (%): 14.348361470447934
Rule of 40 score: 14.348361470447934
Financial ratios for ALKEM.NS — quarterly report dated 2025-12-31
Total revenue: 416266013.14470315
Gross profit: 274491478.2221232
Operating income: 81651999.55441685
Net income: 72744792.24685307
Capital expenditures: 0
Depreciation & amortization: 10583713.935613234
Owner earnings: 83328506.1824663
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 60.84950428873789
P/E ratio: 26.319891147505782
Shares outstanding: 119565000
Market cap (USD): 7275470980.282946
Effective tax rate (%): 16.34280593958013
Interest coverage ratio: 17.410688836104512
COGS to revenue (%): 34.05863809335211
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -7.715851911813901
Rule of 40 score: -7.715851911813901
Financial ratios for AMRUTANJAN.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.203217723855994
Shares outstanding: 28900081
Market cap (USD): 294873818.68007386
Buyback yield (%): 0
Retained earnings: 28316101.806672823
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMRUTANJAN.NS — annual report dated 2023-03-31
Total revenue: 46068842.87454324
Gross profit: 23903361.75395859
Operating income: 5123495.736906213
Net income: 4851997.563946407
Capital expenditures: 1081985.383678441
Operating cash flow: 2458099.8781973207
Depreciation & amortization: 634774.665042631
Net tangible assets: 35114250.9135201
Owner earnings: 4404786.845310598
Return on net tangible assets (%): 12.544157231657236
Capex to operating income (%): 21.118108401741157
Buffett classification: The Great
Stock price: 6.875883069427528
P/E ratio: 40.95500359059518
Shares outstanding: 28900081
Book value: 35416796.58952497
P/B ratio: 5.610715727795568
Market cap (USD): 198713577.65298417
Debt to equity: 0.003126505690543
Current ratio: 4.1253584628983955
Quick ratio: 3.6679050531564577
Effective tax rate (%): 25.74405261215314
Interest coverage ratio: 545.5758754863814
COGS to revenue (%): 48.11382213559541
SG&A to revenue (%): 20.402315868958496
Free cash flow (dilution-adjusted): 1317503.0450669916
Buyback yield (%): 0
Retained earnings: 29219317.90499391
Inventory turnover: 6.313199260366833
Receivables turnover: 11.454323552481352
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.064374490940923
FCF margin (%): 2.859857037553289
Rule of 40 score: 2.859857037553289
Financial ratios for AMRUTANJAN.NS — annual report dated 2024-03-31
Total revenue: 50380213.4548507
Gross profit: 24978270.775872406
Operating income: 5758232.401966663
Net income: 5393044.729583883
Capital expenditures: 774565.2955989927
Operating cash flow: 3346996.04269097
Depreciation & amortization: 726334.0928168845
Net tangible assets: 34309881.28072911
Owner earnings: 5344813.526801774
Return on net tangible assets (%): 15.578058936052935
Capex to operating income (%): 13.451442066396075
Buffett classification: The Great
Stock price: 7.348248560460652
P/E ratio: 39.37756670930336
Shares outstanding: 28900081
Book value: 34595071.35148099
P/B ratio: 6.138590565339448
Market cap (USD): 212364978.60544625
Debt to equity: 0.0059908842057026235
Current ratio: 4.228950849918118
Quick ratio: 3.8155452419602818
Effective tax rate (%): 27.40031640461047
Interest coverage ratio: 306.43203573707723
COGS to revenue (%): 50.420474501845426
SG&A to revenue (%): 18.7304074115861
Free cash flow (dilution-adjusted): 2515637.3665907183
Buyback yield (%): 1.626281103243965
Retained earnings: 28326310.109125793
Inventory turnover: 7.328455233923895
Receivables turnover: 8.772726323570561
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.170245581612125
FCF margin (%): 4.993304303573783
Revenue growth (%): 9.358538898075604
Rule of 40 score: 14.351843201649388
Financial ratios for AMRUTANJAN.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 35318800.76445294
Buffett classification: The Gruesome
Stock price: 9.655279503105591
Shares outstanding: 28900081
Book value: 35569541.32823698
P/B ratio: 7.8448680893131435
Market cap (USD): 279038359.7173913
Debt to equity: 0.007435486026645783
Current ratio: 4.053236034128996
Quick ratio: 3.6204203654555993
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMRUTANJAN.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.355635854994755
Shares outstanding: 28900081
Market cap (USD): 241478553.0158527
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMRUTANJAN.NS — quarterly report dated 2025-03-31
Total revenue: 15830441.898527004
Gross profit: 7764765.02221183
Operating income: 1879787.234042553
Net income: 1774351.1807341594
Capital expenditures: 0
Depreciation & amortization: 189642.27262099602
Net tangible assets: 37980652.326397
Owner earnings: 1963993.4533551554
Return on net tangible assets (%): 5.171036654339285
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.561325708950869
P/E ratio: 30.789131236924305
Shares outstanding: 28900081
Book value: 38182674.77203648
P/B ratio: 5.723091081510621
Market cap (USD): 218522925.45606253
Debt to equity: 0.006362544723965186
Current ratio: 3.4365061537188324
Quick ratio: 3.114221533877966
Effective tax rate (%): 27.224691571129235
Interest coverage ratio: 371.35565819861426
COGS to revenue (%): 50.950421523392045
SG&A to revenue (%): 11.725040911695723
Buyback yield (%): 0
Retained earnings: 31909819.967266772
Inventory turnover: 2.53097234755941
Receivables turnover: 2.425819303569573
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.774189679006949
Rule of 40 score: 0
Financial ratios for AMRUTANJAN.NS — annual report dated 2025-03-31
Total revenue: 52819300.9118541
Gross profit: 26725391.629646946
Operating income: 6040974.982464343
Net income: 5942798.69067103
Capital expenditures: 4156289.455225625
Operating cash flow: 5950339.022679448
Depreciation & amortization: 762929.6235679213
Net tangible assets: 37980652.326397
Owner earnings: 2549438.8590133265
Return on net tangible assets (%): 6.712467277033671
Capex to operating income (%): 68.80163330075763
Buffett classification: The Good
Stock price: 7.561325708950869
P/E ratio: 36.771046241074686
Shares outstanding: 28900081
Book value: 38182674.77203648
P/B ratio: 5.723091081510621
Market cap (USD): 218522925.45606253
Debt to equity: 0.006362544723965186
Current ratio: 3.4365061537188324
Quick ratio: 3.114221533877966
Effective tax rate (%): 26.46932045014031
Interest coverage ratio: 235.7413321167883
COGS to revenue (%): 49.402223868417316
SG&A to revenue (%): 12.418852529224818
Free cash flow (dilution-adjusted): 1660194.061257891
Buyback yield (%): 0
Retained earnings: 31909819.967266772
Inventory turnover: 8.188148849221198
Receivables turnover: 8.093904173638258
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.342566376726218
FCF margin (%): 3.143157960436575
Revenue growth (%): 4.8413599104522245
Rule of 40 score: 7.9845178708888
Financial ratios for AMRUTANJAN.NS — quarterly report dated 2025-06-30
Total revenue: 11004645.448162884
Gross profit: 5225310.086590218
Operating income: 809361.104610344
Net income: 972525.1579686403
Capital expenditures: 0
Depreciation & amortization: 179113.03533816992
Owner earnings: 1151638.1933068102
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.368710507839927
P/E ratio: 88.04779746886626
Shares outstanding: 28900081
Market cap (USD): 241856411.54212502
Effective tax rate (%): 26.402011919204437
Interest coverage ratio: 134.30679611650484
COGS to revenue (%): 52.51723364279282
SG&A to revenue (%): 7.835977615138172
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -30.484281369385858
Rule of 40 score: -30.484281369385858
Financial ratios for AMRUTANJAN.NS — quarterly report dated 2025-09-30
Total revenue: 13269470.124013528
Gross profit: 6769470.124013528
Operating income: 1687519.7294250282
Net income: 1574024.8027057496
Capital expenditures: 0
Depreciation & amortization: 175614.43066516347
Net tangible assets: 38349571.58962796
Owner earnings: 1749639.2333709132
Return on net tangible assets (%): 4.562343621705859
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.02108229988726
P/E ratio: 53.648514647303756
Shares outstanding: 28900081
Book value: 38564565.95264938
P/B ratio: 6.010956494597415
Market cap (USD): 231809928.1744081
Debt to equity: 0.00564946646526404
Current ratio: 3.685981421601961
Quick ratio: 3.2380977012291816
Effective tax rate (%): 27.339720737552625
Interest coverage ratio: 301.17303822937623
COGS to revenue (%): 48.98462364549933
SG&A to revenue (%): 11.681798331693575
Buyback yield (%): 0
Inventory turnover: 1.624034184856244
Receivables turnover: 3.0727913533834585
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.239181566613546
Revenue growth (%): 20.580623760384164
Rule of 40 score: 20.580623760384164
Financial ratios for AMRUTANJAN.NS — quarterly report dated 2025-12-31
Total revenue: 15711117.29976607
Gross profit: 8604790.018937284
Operating income: 2622702.461846942
Net income: 2166893.17143812
Capital expenditures: 0
Depreciation & amortization: 180951.3200401025
Owner earnings: 2347844.4914782224
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.435557535925143
P/E ratio: 33.121921674195285
Shares outstanding: 28900081
Market cap (USD): 214888215.06839705
Effective tax rate (%): 26.21681080260962
Interest coverage ratio: 491.52400835073064
COGS to revenue (%): 45.23120249973944
SG&A to revenue (%): 15.130315296439914
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 18.40048738143609
Rule of 40 score: 18.40048738143609
Financial ratios for AON.AX — annual report dated 2021-06-30
Operating income: -911608.2706766917
Net income: -877513.5338345864
Capital expenditures: 0
Depreciation & amortization: 2702.2556390977443
Net tangible assets: 4052133.8345864657
Owner earnings: -874811.2781954886
Return on net tangible assets (%): -21.588903869083733
Buffett classification: The Gruesome
Stock price: 0.06766917293233082
Shares outstanding: 1259952824
Book value: 4018569.92481203
P/B ratio: 21.21649420790473
Market cap (USD): 85259965.53383458
Debt to equity: 0
Current ratio: 8.613765682538173
Quick ratio: 8.613765682538173
Free cash flow (dilution-adjusted): -515463.9097744361
Buyback yield (%): 0.040393928625731185
Retained earnings: -38097168.42105263
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.684892579524604
Rule of 40 score: 0
Financial ratios for AON.AX — annual report dated 2022-06-30
Operating income: -1279077.2413793104
Net income: -1253297.2413793104
Capital expenditures: 0
Depreciation & amortization: 2871.7241379310344
Net tangible assets: 7399968.9655172415
Owner earnings: -1250425.5172413792
Return on net tangible assets (%): -16.897712991340597
Buffett classification: The Gruesome
Stock price: 0.034482758620689655
Shares outstanding: 1259952824
Book value: 7364922.068965518
P/B ratio: 5.89913222388663
Market cap (USD): 43446649.10344827
Debt to equity: 0
Current ratio: 3.299607466784138
Quick ratio: 3.299607466784138
Free cash flow (dilution-adjusted): -664092.4137931034
Buyback yield (%): 0.7092900487836045
Retained earnings: -35331688.27586207
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.36715242064972
Rule of 40 score: 0
Financial ratios for AON.AX — annual report dated 2023-06-30
Operating income: -2706294.701986755
Net income: -2673287.417218543
Capital expenditures: 165562.91390728476
Depreciation & amortization: 23476.82119205298
Net tangible assets: 6142343.708609272
Owner earnings: -2815373.509933775
Return on net tangible assets (%): -45.83549282642182
Buffett classification: The Gruesome
Stock price: 0.019867549668874173
Shares outstanding: 1259952824
Book value: 6103458.278145695
P/B ratio: 4.101310137711527
Market cap (USD): 25032175.31125828
Debt to equity: 0
Current ratio: 3.2719443764056204
Quick ratio: 3.2719443764056204
Free cash flow (dilution-adjusted): -2624033.7748344373
Buyback yield (%): 0.025215229804508937
Retained earnings: -36466881.456953645
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -44.34034900634989
Rule of 40 score: 0
Financial ratios for AON.AX — annual report dated 2024-06-30
Operating income: -2360572
Net income: -1941722
Capital expenditures: 0
Depreciation & amortization: 36953.333333333336
Net tangible assets: 7285652
Owner earnings: -1904768.6666666667
Return on net tangible assets (%): -26.144107166615516
Buffett classification: The Gruesome
Stock price: 0.02
Shares outstanding: 1259952824
Book value: 7241173.333333333
P/B ratio: 3.4799686901570284
Market cap (USD): 25199056.48
Debt to equity: 0
Current ratio: 3.0813582871317196
Quick ratio: 3.0813582871317196
Free cash flow (dilution-adjusted): -1742584.6666666667
Buyback yield (%): 0.6885760457117983
Retained earnings: -38379269.333333336
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -32.59930250714434
Rule of 40 score: 0
Financial ratios for ARDX — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 1441000
Buffett classification: The Gruesome
Stock price: 1.1
Shares outstanding: 247029387
Market cap (USD): 271732325.70000005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARDX — annual report dated 2022-12-31
Total revenue: 52158000
Gross profit: 48041000
Operating income: -63759000
Net income: -67207000
Capital expenditures: 1743000
Operating cash flow: -70044000
Depreciation & amortization: 1144000
Net tangible assets: 98329000
Owner earnings: -67806000
Return on net tangible assets (%): -68.95829307732205
Buffett classification: The Gruesome
Stock price: 2.85
Shares outstanding: 247029387
Book value: 98329000
P/B ratio: 7.159980808815304
Market cap (USD): 704033752.95
Debt to equity: 0.370796001179713
Current ratio: 2.3414020700272853
Quick ratio: 2.291373870097404
Interest coverage ratio: -12.568302779420462
COGS to revenue (%): 7.893324130526477
R&D to revenue (%): 67.4891675294298
SG&A to revenue (%): 146.8595421603589
Free cash flow (dilution-adjusted): -80849000
Buyback yield (%): 0
Retained earnings: -780137000
Inventory turnover: 1.2544180377818404
Receivables turnover: 6.744859692228113
Capitalized R&D asset: 35201000
ROCI (R&D-adjusted, %): -25.2352857667769
FCF margin (%): -155.00786073085624
Rule of 40 score: -155.00786073085624
Financial ratios for ARDX — annual report dated 2023-12-31
Total revenue: 124456000
Gross profit: 106661000
Operating income: -63276000
Net income: -66067000
Capital expenditures: 344000
Operating cash flow: -89717000
Depreciation & amortization: 1292000
Net tangible assets: 166816000
Owner earnings: -65119000
Return on net tangible assets (%): -39.03642336466526
Buffett classification: The Gruesome
Stock price: 6.2
Shares outstanding: 247029387
Book value: 166816000
P/B ratio: 9.181266781363899
Market cap (USD): 1531582199.4
Debt to equity: 0.3355913101860733
Current ratio: 4.883833072053658
Quick ratio: 4.636814636953545
Interest coverage ratio: -7.130493576741041
COGS to revenue (%): 14.29822587902552
R&D to revenue (%): 28.553062929870798
SG&A to revenue (%): 107.9907758565276
Free cash flow (dilution-adjusted): -103591000
Buyback yield (%): 0
Retained earnings: -846204000
Inventory turnover: 1.4295469151670952
Receivables turnover: 5.649130770278244
Capitalized R&D asset: 59120670
ROCI (R&D-adjusted, %): -16.754124224588384
Rosenberg metric: 1.6652935996136473
FCF margin (%): -83.235038889246
Revenue growth (%): 138.6134437670156
Rule of 40 score: 55.37840487776961
Financial ratios for ARDX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.89
Shares outstanding: 247029387
Market cap (USD): 1702032476.4299998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARDX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.07
Shares outstanding: 247029387
Market cap (USD): 1252438992.0900002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARDX — annual report dated 2024-12-31
Total revenue: 333615000
Gross profit: 283059000
Operating income: -27950000
Net income: -39136000
Capital expenditures: 1011000
Operating cash flow: -44809000
Depreciation & amortization: 2063000
Net tangible assets: 173289000
Owner earnings: -38084000
Return on net tangible assets (%): -21.9771595427292
Buffett classification: The Gruesome
Stock price: 5.07
Shares outstanding: 247029387
Book value: 173289000
P/B ratio: 7.227458131156623
Market cap (USD): 1252438992.0900002
Debt to equity: 0.8854457005349445
Current ratio: 4.579879223949634
Quick ratio: 4.307837594757806
Interest coverage ratio: -1.3909624763611028
COGS to revenue (%): 15.15399487433119
R&D to revenue (%): 15.681848837732115
SG&A to revenue (%): 77.54207694498149
Free cash flow (dilution-adjusted): -83201000
Buyback yield (%): 0
Retained earnings: -885340000
Inventory turnover: 2.387757993671185
Receivables turnover: 5.781388094619183
Capitalized R&D asset: 87742450
ROCI (R&D-adjusted, %): -3.7362022651693882
Rosenberg metric: 4.963923908149482
FCF margin (%): -24.939226353731097
Revenue growth (%): 168.05859098797967
Rule of 40 score: 143.11936463424857
Financial ratios for ARDX — quarterly report dated 2025-03-31
Total revenue: 74114000
Gross profit: 61811000
Operating income: -36349000
Net income: -41144000
Capital expenditures: 325000
Operating cash flow: -38457000
Depreciation & amortization: 602000
Net tangible assets: 145676000
Owner earnings: -40867000
Return on net tangible assets (%): -28.053351272687333
Buffett classification: The Gruesome
Stock price: 4.91
Shares outstanding: 247029387
Book value: 145676000
P/B ratio: 8.326109243595376
Market cap (USD): 1212914290.17
Debt to equity: 1.0647464235701145
Current ratio: 4.123048523206751
Quick ratio: 3.8095464135021095
Interest coverage ratio: -5.804694985627595
COGS to revenue (%): 16.60010254472839
R&D to revenue (%): 20.155436219877487
SG&A to revenue (%): 112.28917613406375
Free cash flow (dilution-adjusted): -50870000
Buyback yield (%): 0
Retained earnings: -926484000
Inventory turnover: 0.5174545760430687
Receivables turnover: 1.5949813846385608
Capitalized R&D asset: 14938000
ROCI (R&D-adjusted, %): -7.555378689844981
FCF margin (%): -68.63750438513641
Rule of 40 score: -68.63750438513641
Financial ratios for ARDX — quarterly report dated 2025-06-30
Total revenue: 97662000
Gross profit: 85259000
Operating income: -14395000
Net income: -19079000
Capital expenditures: 650000
Operating cash flow: -25342000
Depreciation & amortization: 631000
Net tangible assets: 139531000
Owner earnings: -19098000
Return on net tangible assets (%): -13.687280962653462
Buffett classification: The Gruesome
Stock price: 3.92
Shares outstanding: 247029387
Book value: 139531000
P/B ratio: 6.940072077459488
Market cap (USD): 968355197.04
Debt to equity: 1.4809827206857258
Current ratio: 4.302011698196324
Quick ratio: 4.029441276522846
Interest coverage ratio: -2.1893536121673005
COGS to revenue (%): 12.699924228461429
R&D to revenue (%): 16.04103950359403
SG&A to revenue (%): 85.99864839958224
Free cash flow (dilution-adjusted): -37679000
Buyback yield (%): 0
Retained earnings: -945563000
Inventory turnover: 0.5568125701459035
Receivables turnover: 1.561268044698096
Capitalized R&D asset: 25674460
ROCI (R&D-adjusted, %): -2.174298754768204
Rosenberg metric: 1.569688043914848
FCF margin (%): -38.58102434928632
Revenue growth (%): 31.772674528429178
Rule of 40 score: -6.8083498208571385
Financial ratios for ARDX — quarterly report dated 2025-09-30
Total revenue: 110329000
Gross profit: 106347000
Operating income: 4668000
Net income: -969000
Capital expenditures: 156000
Operating cash flow: 365000
Depreciation & amortization: 905000
Net tangible assets: 154280000
Owner earnings: -220000
Return on net tangible assets (%): -0.14259787399533316
Capex to operating income (%): 3.3419023136246784
Buffett classification: The Great
Stock price: 5.51
Shares outstanding: 247029387
Book value: 154280000
P/B ratio: 8.822478107142857
Market cap (USD): 1361131922.37
Debt to equity: 1.3456766917293232
Current ratio: 4.412872201369485
Quick ratio: 4.111009845423257
Interest coverage ratio: 0.5846693386773547
COGS to revenue (%): 3.609205195370211
R&D to revenue (%): 16.375567620480563
SG&A to revenue (%): 75.7842453026856
Free cash flow (dilution-adjusted): -12533000
Buyback yield (%): 0
Retained earnings: -946532000
Inventory turnover: 0.15819164150643572
Receivables turnover: 1.4401383631379716
Capitalized R&D asset: 33492760
ROCI (R&D-adjusted, %): 1.492487958325372
Rosenberg metric: 1.3460998340354908
FCF margin (%): -11.359660651324674
Revenue growth (%): 12.97024431201491
Rule of 40 score: 1.610583660690235
Financial ratios for ARDX — annual report dated 2025-12-31
Total revenue: 407320000
Gross profit: 367783000
Operating income: -40977000
Net income: -61599000
Capital expenditures: 1492000
Operating cash flow: -42483000
Depreciation & amortization: 3059000
Net tangible assets: 166949000
Owner earnings: -60032000
Return on net tangible assets (%): -35.95828666239391
Buffett classification: The Gruesome
Stock price: 5.83
Shares outstanding: 247029387
Book value: 166949000
P/B ratio: 8.62647470910278
Market cap (USD): 1440181326.21
Debt to equity: 1.2456139300025757
Current ratio: 4.314846791941764
Quick ratio: 4.114688787314486
Interest coverage ratio: -1.4429537291358547
COGS to revenue (%): 9.706618874594913
R&D to revenue (%): 17.560394775606404
SG&A to revenue (%): 82.79313561818718
Free cash flow (dilution-adjusted): -92937000
Buyback yield (%): 0
Retained earnings: -946939000
Inventory turnover: 2.2293205525796447
Receivables turnover: 5.6691905133058675
Capitalized R&D asset: 118306270
ROCI (R&D-adjusted, %): -4.249283404748962
Rosenberg metric: 1.619435365177667
FCF margin (%): -22.816704311106747
Revenue growth (%): 22.09283155733405
Rule of 40 score: -0.7238727537726959
Financial ratios for ARDX — quarterly report dated 2025-12-31
Total revenue: 125215000
Gross profit: 114366000
Operating income: 5099000
Net income: -407000
Capital expenditures: 361000
Operating cash flow: 20951000
Depreciation & amortization: 921000
Net tangible assets: 166949000
Owner earnings: 153000
Capex to operating income (%): 7.079819572465189
Buffett classification: The Great
Stock price: 5.83
Shares outstanding: 247029387
Book value: 166949000
P/B ratio: 8.62647470910278
Market cap (USD): 1440181326.21
Debt to equity: 1.2456139300025757
Current ratio: 4.314846791941764
Quick ratio: 4.114688787314486
Interest coverage ratio: 0.6729576349478685
COGS to revenue (%): 8.664297408457452
R&D to revenue (%): 18.25340414487082
SG&A to revenue (%): 69.0101026234876
Free cash flow (dilution-adjusted): 8145000
Buyback yield (%): 0
Retained earnings: -946939000
Inventory turnover: 0.6117282210318579
Receivables turnover: 1.7427764168800801
Capitalized R&D asset: 40130670
ROCI (R&D-adjusted, %): 2.0064896655299576
Rosenberg metric: 0.44384789948524933
FCF margin (%): 6.504811723835004
Revenue growth (%): 13.492372812225254
Rule of 40 score: 19.997184536060256
Financial ratios for AXE.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.6917293233082706
Shares outstanding: 280254429
Market cap (USD): 193860206.52631578
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AXE.AX — annual report dated 2022-06-30
Operating income: -9809596.551724138
Net income: -9734984.827586208
Capital expenditures: 17848.275862068967
Depreciation & amortization: 34762.75862068966
Net tangible assets: 20117904.137931034
Owner earnings: -9718070.344827587
Return on net tangible assets (%): -48.30558033381212
Buffett classification: The Gruesome
Stock price: 0.37931034482758624
Shares outstanding: 280254429
Book value: 20289173.10344828
P/B ratio: 5.239415305958493
Market cap (USD): 106303404.10344829
Debt to equity: 0.000671293991655342
Current ratio: 42.899717453227446
Quick ratio: 42.899717453227446
Free cash flow (dilution-adjusted): -3062360.6896551726
Buyback yield (%): 0.6422735249618481
Retained earnings: -20136277.24137931
Capitalized R&D asset: 1557977.9310344828
ROCI (R&D-adjusted, %): -40.083061687281166
Rule of 40 score: 0
Financial ratios for AXE.AX — annual report dated 2023-06-30
Operating income: -6888599.337748344
Net income: -5993017.880794702
Capital expenditures: 40001.32450331126
Depreciation & amortization: 35588.741721854305
Net tangible assets: 16984465.562913906
Owner earnings: -5997430.4635761585
Return on net tangible assets (%): -35.31126982689246
Buffett classification: The Gruesome
Stock price: 0.3973509933774834
Shares outstanding: 280254429
Book value: 17218700
P/B ratio: 6.4673509476086695
Market cap (USD): 111359375.7615894
Debt to equity: 0.00034988142608084684
Current ratio: 22.80190664608191
Quick ratio: 22.80190664608191
Free cash flow (dilution-adjusted): -2126571.523178808
Buyback yield (%): 0
Retained earnings: -24616368.21192053
Capitalized R&D asset: 3007792.2336606532
ROCI (R&D-adjusted, %): -30.11718402565698
Rule of 40 score: 0
Financial ratios for AXE.AX — annual report dated 2024-06-30
Operating income: -5048408.666666667
Net income: -3202100
Capital expenditures: 77576.66666666667
Depreciation & amortization: 121129.33333333333
Net tangible assets: 14198284
Owner earnings: -3158547.333333333
Return on net tangible assets (%): -22.245979396759026
Buffett classification: The Gruesome
Stock price: 0.22666666666666668
Shares outstanding: 280254429
Book value: 14533453.333333334
P/B ratio: 4.370904545742283
Market cap (USD): 63524337.24
Debt to equity: 0.005014132910829177
Current ratio: 21.047915504700846
Quick ratio: 21.047915504700846
Free cash flow (dilution-adjusted): -3327882
Buyback yield (%): 0
Retained earnings: -26812324.666666668
Capitalized R&D asset: 4846103.887219304
ROCI (R&D-adjusted, %): -21.702933087123473
Rule of 40 score: 0
Financial ratios for AXP.TO — quarterly report dated 2025-12-31
Total revenue: 13854744525.547443
Net income: 1797080291.9708028
Capital expenditures: 526277372.2627737
Operating cash flow: 2238686131.3868613
Depreciation & amortization: 337226277.3722628
Net tangible assets: 20810948905.109486
Owner earnings: 1608029197.0802917
Return on net tangible assets (%): 7.726842271404019
Buffett classification: The Gruesome
Stock price: 23.124087591240873
P/E ratio: 31.138655532112576
Shares outstanding: 10500278047
Book value: 24433576642.335754
P/B ratio: 9.93752788818068
Market cap (USD): 242809349291.21164
Debt to equity: 1.7254884387883138
Effective tax rate (%): 20.323624595469255
COGS to revenue (%): 0
SG&A to revenue (%): 21.690111163795375
Free cash flow (dilution-adjusted): 1609489051.0948906
Buyback yield (%): 0.27025498872987375
Retained earnings: 18603649635.036495
Capitalized R&D asset: 0
FCF margin (%): 11.61688003793267
Revenue growth (%): 4.515873713833417
Rule of 40 score: 16.13275375176609
Financial ratios for AXP.TO — annual report dated 2025-12-31
Total revenue: 52722627737.22627
Net income: 7907299270.072992
Capital expenditures: 1770072992.7007298
Operating cash flow: 13451094890.510948
Depreciation & amortization: 1297080291.9708028
Net tangible assets: 20810948905.109486
Owner earnings: 7434306569.343065
Return on net tangible assets (%): 35.723054259759394
Buffett classification: The Gruesome
Stock price: 23.124087591240873
P/E ratio: 30.70698869463306
Shares outstanding: 10500278047
Book value: 24433576642.335754
P/B ratio: 9.93752788818068
Market cap (USD): 242809349291.21164
Debt to equity: 1.7254884387883138
Effective tax rate (%): 21.471547662196446
COGS to revenue (%): 0
SG&A to revenue (%): 21.138031288938116
Free cash flow (dilution-adjusted): 11278832116.78832
Buyback yield (%): 1.7477892152118863
Retained earnings: 18603649635.036495
Capitalized R&D asset: 0
FCF margin (%): 21.392773085975357
Revenue growth (%): 14.320698819138366
Rule of 40 score: 35.71347190511372
Financial ratios for AZY.AX — annual report dated 2021-06-30
Operating income: -3243428.5714285714
Net income: -2674374.4360902254
Capital expenditures: 123109.77443609021
Depreciation & amortization: 57051.879699248115
Net tangible assets: 46178329.32330827
Owner earnings: -2740432.3308270676
Return on net tangible assets (%): -5.934455340816864
Buffett classification: The Gruesome
Stock price: 0.3082706766917293
Shares outstanding: 663812262
Book value: 46052630.827067666
P/B ratio: 4.443478071240459
Market cap (USD): 204633855.20300752
Debt to equity: 0.008862432797754005
Current ratio: 3.1241586612737042
Quick ratio: 3.1241586612737042
Free cash flow (dilution-adjusted): -3541327.067669173
Buyback yield (%): 0.6556970713167709
Retained earnings: -13185407.518796992
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.987445175510529
Rule of 40 score: 0
Financial ratios for AZY.AX — annual report dated 2022-06-30
Operating income: -4417975.172413793
Net income: -4038752.413793104
Capital expenditures: 28644.137931034482
Depreciation & amortization: 74200.68965517242
Net tangible assets: 41170140
Owner earnings: -3993195.8620689656
Return on net tangible assets (%): -9.699252570112623
Buffett classification: The Gruesome
Stock price: 0.22068965517241382
Shares outstanding: 663812262
Book value: 41170140
P/B ratio: 3.5583191895874053
Market cap (USD): 146496499.20000002
Debt to equity: 0.008138975447270514
Current ratio: 2.218933493994718
Quick ratio: 2.218933493994718
Free cash flow (dilution-adjusted): -16834888.275862068
Buyback yield (%): 0.005879862761558929
Retained earnings: -16132954.48275862
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.654466609316739
Rule of 40 score: 0
Financial ratios for AZY.AX — annual report dated 2023-06-30
Operating income: -2304454.304635762
Net income: -2155607.284768212
Capital expenditures: 1756.953642384106
Depreciation & amortization: 68300
Net tangible assets: 45403958.94039735
Owner earnings: -2089064.2384105963
Return on net tangible assets (%): -4.601061861484261
Buffett classification: The Gruesome
Stock price: 0.08609271523178808
Shares outstanding: 663812262
Book value: 45403958.94039735
P/B ratio: 1.2586875984703494
Market cap (USD): 57149400.03973509
Debt to equity: 0.006115141985605654
Current ratio: 2.6880959512039553
Quick ratio: 2.6880959512039553
Free cash flow (dilution-adjusted): -8319119.205298013
Buyback yield (%): 0.913945849253477
Retained earnings: -17647517.218543045
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.048768121100119
Rule of 40 score: 0
Financial ratios for AZY.AX — annual report dated 2024-06-30
Operating income: -2027421.3333333333
Net income: -1628845.3333333333
Capital expenditures: 6712
Depreciation & amortization: 61961.333333333336
Net tangible assets: 52435934
Owner earnings: -1573596
Return on net tangible assets (%): -3.000987834029999
Buffett classification: The Gruesome
Stock price: 0.06666666666666667
Shares outstanding: 663812262
Book value: 52435934
P/B ratio: 0.843966101566914
Market cap (USD): 44254150.8
Debt to equity: 0.004346179854448668
Current ratio: 4.011074433371591
Quick ratio: 4.011074433371591
Free cash flow (dilution-adjusted): -6485534
Buyback yield (%): 1.1719608758899365
Retained earnings: -19394012.666666668
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.8525190992600837
Rule of 40 score: 0
Financial ratios for BCG.L — annual report dated 2022-04-30
Total revenue: 63698750
Operating income: 17093750
Net income: 1365000
Capital expenditures: 0
Operating cash flow: 26035000
Depreciation & amortization: 21117500
Net tangible assets: -91390000
Owner earnings: 22482500
Return on net tangible assets (%): -24.600612758507495
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.01575
P/E ratio: 4.885667538461538
Shares outstanding: 423424520
Book value: 409221250
P/B ratio: 0.016296651725686288
Market cap (USD): 6668936.19
Debt to equity: 0.25292247164583953
Current ratio: 2.6237207186718217
Quick ratio: 2.6237207186718217
Effective tax rate (%): 55.33742331288344
Interest coverage ratio: 3.1307234432234434
COGS to revenue (%): 0
SG&A to revenue (%): 1.6503463568751346
Free cash flow (dilution-adjusted): 23478750
Buyback yield (%): 0
Retained earnings: 764846250
Receivables turnover: 17.38621630842716
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.289639859609958
FCF margin (%): 36.85904354481053
Rule of 40 score: 36.85904354481053
Financial ratios for BCG.L — annual report dated 2023-04-30
Total revenue: 76017500
Operating income: 36418750
Net income: 29018750
Capital expenditures: 5000
Operating cash flow: 53326250
Depreciation & amortization: 21236250
Net tangible assets: -66226250
Owner earnings: 50250000
Return on net tangible assets (%): -75.87625752628301
Capex to operating income (%): 0.013729191693839026
Buffett classification: The Great
Stock price: 0.019625
P/E ratio: 0.28635644902003016
Shares outstanding: 423424520
Book value: 415815000
P/B ratio: 0.019984142479227543
Market cap (USD): 8309706.205
Debt to equity: 0.20950723278381012
Current ratio: 2.624120775433179
Quick ratio: 2.624120775433179
Effective tax rate (%): 11.94765787976484
Interest coverage ratio: 11.132976690867405
COGS to revenue (%): 0
SG&A to revenue (%): 1.5966718189890488
Free cash flow (dilution-adjusted): 51053750
Buyback yield (%): 85.18652555659156
Retained earnings: 774982500
Receivables turnover: 18.55782728104974
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.174235298173383
FCF margin (%): 67.16052224816654
Revenue growth (%): 19.339076512490433
Rule of 40 score: 86.49959876065698
Financial ratios for BCG.L — annual report dated 2024-04-30
Total revenue: 90083750
Operating income: 47983750
Net income: 40060000
Capital expenditures: 3750
Operating cash flow: 63997500
Depreciation & amortization: 21147500
Net tangible assets: -43931250
Owner earnings: 61203750
Return on net tangible assets (%): -139.31711481007255
Capex to operating income (%): 0.007815145752468283
Buffett classification: The Great
Stock price: 0.028375
P/E ratio: 0.29991689353469797
Shares outstanding: 423424520
Book value: 417692500
P/B ratio: 0.028764391879193427
Market cap (USD): 12014670.755
Debt to equity: 0.15052041872908897
Current ratio: 2.1956131157358887
Quick ratio: 2.1956131157358887
Effective tax rate (%): 8.240279447975722
Interest coverage ratio: 10.80106921778278
COGS to revenue (%): 0
SG&A to revenue (%): 1.4431015582721634
Free cash flow (dilution-adjusted): 60908750
Buyback yield (%): 203.29312802712752
Retained earnings: 776362500
Receivables turnover: 17.913745960725826
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.919916065627996
FCF margin (%): 67.61347079800741
Revenue growth (%): 18.50396290327885
Rule of 40 score: 86.11743370128626
Financial ratios for BCG.L — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: -41823376.62337662
Buffett classification: The Gruesome
Stock price: 0.040389610389610385
Shares outstanding: 423424520
Book value: 429706493.5064935
P/B ratio: 0.03979914581381432
Market cap (USD): 17101951.39220779
Debt to equity: 0.13699776954369336
Current ratio: 2.0479157052761114
Quick ratio: 2.0479157052761114
Buyback yield (%): 0
Retained earnings: 803267532.4675324
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCG.L — annual report dated 2025-04-30
Total revenue: 110414666.66666667
Operating income: 71382666.66666667
Net income: 59674666.666666664
Capital expenditures: 0
Operating cash flow: 76489333.33333333
Depreciation & amortization: 14517333.333333334
Net tangible assets: -14728000
Owner earnings: 74192000
Return on net tangible assets (%): -503.74796306355245
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.0448
P/E ratio: 0.31788059415497366
Shares outstanding: 423424520
Book value: 465337333.3333334
P/B ratio: 0.04076487557986608
Market cap (USD): 18969418.496
Debt to equity: 0.07266413182694705
Current ratio: 2.098304833814494
Quick ratio: 2.098304833814494
Effective tax rate (%): 12.414872798434443
Interest coverage ratio: 20.815318818040435
COGS to revenue (%): 0
SG&A to revenue (%): 1.335571361292582
Free cash flow (dilution-adjusted): 73516000
Buyback yield (%): 96.74519018002479
Retained earnings: 848860000
Receivables turnover: 19.586329233680228
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.227061099536545
FCF margin (%): 66.58173431065921
Revenue growth (%): 22.568905786744747
Rule of 40 score: 89.15064009740397